I’ve really enjoyed day 2 of ISSCR 2014. So far this day has already packed in a slew of great talks both in the lecture halls and outside one-on-one with old friends and new ones. How great is that? I’ll focus on just a few highlights to keep it concise. Dubious stem cell clinics and […]
ISSCR 2014 Day 2: Navigating Balanced Stem Cell Path to Clinic Read More »
What would be the World Cup of Stem Cells? This morning at ISSCR 2014 in Vancouver things kicked off in an exciting way, kind of akin to a World Cup soccer/football match for fans of stem cells. Azim Surani (pictured at right) received the McEwen Award for his innovative research on germ cell fate and epigenetic
Kick Off of ISSCR 2014: Some Top Highlights Of World Cup of Stem Cells Read More »
What’s the biggest stem cell story of the year so far? I did a poll asking just that and the result so far overwhelmingly indicate that respondents believe the STAP cell scandal to be the top stem cell story of 2014 about half way through the year. You can see the results from the 210+
Poll indicates that STAP cells are stem cell story of the year so far Read More »
Is Neuralstem flirting with noncompliance via a Right To Try Law in Colorado? Colorado is an independent-minded state. For example, it is one of only a few states including Washington State with legalized marijuana use. More recently, Colorado passed a new law supported by the ultra-conservative Goldwater Institute, the so-called Right To Try Law. This law
Neuralstem flirting with noncompliance via Right To Try Law? Read More »
There is more good news from leading stem cell biotech Advanced Cell Technology (ACT) on preclinical rodent studies using stem cells to treat mice with an MS-like condition. They published a new paper in the journal Stem Cell Reports entitled “Human ESC-Derived MSCs Outperform Bone Marrow MSCs in the Treatment of an EAE Model of
Advanced Cell Technology (ACT) Revs Up Pre-Clinical Studies for MS Read More »
Now that it appears that the authors have all consented to eventually have both of their STAP cell Nature papers retracted, what’s next for STAP? Who knows, but below is my attempt at a top 10 list of STAP predictions looking ahead. I hope I’m wrong about several of them. 10. No insight will come
STAP cell predictions Read More »
ISSCR and I held a short essay contest for a free registration to ISSCR 2014 in Vancouver. The winning piece was written by student Mohamed Gatie, but there was a great 2nd place essay by Sherry Hikita that deserved acknowledgment. I’m publishing that essay below and Sherry will be receiving a free signed copy of my book and a free stem cell
Great 2nd Place ISSCR Essay Related to Vision and Stem Cells Read More »
It’s been an important week for stem cells. Although I’ve been busy working on multiple grants and papers, when I take a break I like to read up on what’s been going on with stem cells. What are the top stem cell stories and headlines of the week? CIRM awarded Asterias (a subsidiary of BioTime)
TGIF stem cell headlines of week: Asterias, lasers, immunity, & more Read More »
Japanese news media are reporting that Haruko Obokata and other key authors have agreed to retract the Nature STAP cell letter, but not the Nature article. This is a major development and a peculiar one because to many in the field it is the Nature STAP cell article that is the more flawed of the two Nature papers on STAP. Why would
Obokata OKs Retraction of Nature STAP Cell Letter, Not Article Read More »
Two stem cell papers riddled with errors, with figures that resulted from potential misconduct, with plagiarism, and with other serious problems remain uncorrected and unretracted in the prestigious journal Nature. It is well past time for the journal to editorially retract them. It was about four months ago that Nature published the two astonishing STAP papers reporting the
Past Time for Nature to Retract STAP Cell Pubs, Open up on Review Problems Read More »